The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Cherdak M.A.

Pirogov Russian National Research Medical University

Mkhitaryan E.A.

Pirogov Russian National Research Medical University;
Russian Clinical and Research Center of Gerontology Pirogov — Russian National Research Medical University

Zaharov V.V.

Sechenov First Moscow State Medical University (Sechenov University)

Voznesenskiy N.A.

Severtsov Institute of Ecology and Evolution

Vitamin B12 in the treatment and prevention of cognitive disorders in the elderly

Authors:

Cherdak M.A., Mkhitaryan E.A., Zaharov V.V., Voznesenskiy N.A.

More about the authors

Read: 24525 times


To cite this article:

Cherdak MA, Mkhitaryan EA, Zaharov VV, Voznesenskiy NA. Vitamin B12 in the treatment and prevention of cognitive disorders in the elderly. S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(1):43‑49. (In Russ.)
https://doi.org/10.17116/jnevro202212201143

Recommended articles:
The possibilities of Mexi­dol in the complex therapy of arte­rial hype­rtension. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):572-580
Unre­solved problem: Chemotherapy-Induced Peri­pheral Neuropathy. P.A. Herzen Journal of Onco­logy. 2024;(5):76-81
Analysis of medi­cal preventive stru­ctures staff resources in 2023. Russian Journal of Preventive Medi­cine. 2024;(10):45-51
Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):517-524
Tube­rculous otitis media in an adolescent. Clinical case. Russian Bulletin of Otorhinolaryngology. 2024;(5):63-66

References:

  1. Wu YT, Beiser AS, Breteler MMB, et al. The changing prevalence and incidence of dementia over time — current evidence. Nat Rev Neurol. 2017;13(6):327-339.  https://doi.org/10.1038/nrneurol.2017.63
  2. Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010—2050) estimated using the 2010 census. Neurology. 2013;80(19):1778-1783. https://doi.org/10.1212/WNL.0b013e31828726f5
  3. Alzheimer’s Association. 2021 Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17(3):327-406.  https://doi.org/10.1002/alz.12328
  4. Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of Lancet Commission. Lancet. 2020;396(10248):413-446.  https://doi.org/10.1016/S0140-6736(20)30367-6
  5. Ford AH, Almeida OP. Effect of Vitamin B Supplementation on Cognitive Function in the Elderly: A Systematic Review and Meta-Analysis. Drugs Aging. 2019;36(5):419-434.  https://doi.org/10.1007/s40266-019-00649-w
  6. Dali-Youcef N, Andrès E. An update on cobalamin deficiency in adults. QJM. 2009;102(1):17-28.  https://doi.org/10.1093/qjmed/hcn138
  7. Kerkeshko GO, Dorofeykov VV, Patrukhina NA, Mozgovaya EV. The role of active vitamin (holotranscobalamin) in the development of anemia of pregnancy. Journal of Obstetrics and Women’s Diseases. 2015;64(5):96-105. (In Russ.). https://doi.org/10.17816/JOWD64596-105
  8. Andrès E, Loukili NH, Noel E, et al. Vitamin (cobalamin) deficiency in elderly patients. CMAJ. 2004;171(3):251-259.  https://doi.org/10.1503/cmaj.1031155
  9. Hunt A, Harrington D, Robinson S. Vitamin deficiency. BMJ. 2014;349:g5226. https://doi.org/10.1136/bmj.g5226
  10. Nexo E, Hoffmann-Lücke E. Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr. 2011;94(1):359-365.  https://doi.org/10.3945/ajcn.111.013458
  11. Nexo E, Hvas AM, Bleie Ø, et al. Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study. Clin Chem. 2002;48(10):1768-1771.
  12. Pavlov CS, Damulin IV, Shulpekova YO, Andreev EA. Neurological disorders in vitamin deficiency. Terapevticheskii Arkhiv. 2019;91(4):122-129. (In Russ.). https://doi.org/10.26442/00403660.2019.04.000116
  13. Andrès E, Zulfiqar AA, Vogel T. State of the Art Review: Oral and nasal vitamin therapy in the elderly. QJM. 2020;113:5-15.  https://doi.org/10.1093/qjmed/hcz046
  14. Green R, Allen LH, Bjørke-Monsen AL, et al. Vitamin deficiency. Nat Rev Dis Primers. 2017;3:17040. https://doi.org/10.1038/nrdp.2017.40
  15. Hvas AM, Nexo E. Diagnosis and treatment of vitamin deficiency: an update. Haematologica. 2006;91:1506-1512.
  16. Herrmann W, Obeid R. Causes and early diagnosis of vitamin deficiency. Dtsch Arztebl Int. 2008;105(40):680-685.  https://doi.org/10.3238/arztebl.2008.0680
  17. Boucher JL. The cause of multiple sclerosis is autoimmune attack of adenosyltransferase thereby limiting adenosylcobalamin production. Med Hypoth. 2017;109:29-37.  https://doi.org/10.1016/j.mehy.2017.08.011
  18. Nishimoto S, Tanaka H, Okamoto M, et al. Methylcobalamin promotes the differentiation of Schwann cells and remyelination in lysophosphatidylcholine — induced demyelination of the rat sciatic nerve. Front Cell Neurosci. 2015;9:298.  https://doi.org/10.3389/fncel.2015.00298
  19. Liao WC, Wang YJ, Huang MC, Tseng GF. Methylcobalamin Facilitates Collateral Sprouting of Donor Axons and Innervation of Recipient Muscle in End-to-Side Neurorrhaphy in Rats. PLoS ONE. 2013;8(9):e76302. https://doi.org/10.1371/journal.pone.0076302
  20. Pankiv IV. Vitamin levels in metformin-treated type 2 diabetes patients. Clin Endocrinol Endocrin Surg. 2019;4(68):45-50.  https://doi.org/10.30978/CEES-2019-4-45
  21. Ostroumova OD, Pereverzev AP. Influence of proton pump inhibitors on cognitive function and dementia risk. Consilium Medicum. 2019;21(2):31-36. (In Russ.). https://doi.org/10.26442/20751753.2019.2.180171
  22. Dries LS, Haefliger R, Seibert BS, et al. Cognition, oxidative stress and vitamin levels evaluation on patients under long-term omeprazole use. J Pharm Pharmacol. 2021:rgab001. https://doi.org/10.1093/jpp/rgab001
  23. Didangelos T, Karlafti E, Kotzakioulafi E, et al. Vitamin Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2021;13(2):395.  https://doi.org/10.3390/nu13020395
  24. Andrès E, Affenberger S, Vinzio S, et al. Food-cobalamin malabsorption in elderly: clinical manifestations and treatment. Am J Med. 2005;118(10):1154-1159. https://doi.org/10.1016/j.amjmed.2005.02.026
  25. Lindenbaum J, Rosenberg IH, Wilson PW, et al. Prevalence of cobalamin deficiency in Framingham elderly population. Am J Clin Nutr. 1994;60(1):2-11.  https://doi.org/10.1093/ajcn/60.1.2
  26. Garcia A, Paris-Pombo A, Evans L, et al. Is low-dose oral cobalamin enough to normalize cobalamin function in older? J Am Geriatr Soc. 2002;50(8):1401-1404. https://doi.org/10.1046/j.1532-5415.2002.50362.x
  27. van Asselt DZ, de Groot LC, van Staveren WA, et al. Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr. 1998;68(2):328-334.  https://doi.org/10.1093/ajcn/68.2.328
  28. Perekatova TN, Ostroumova MN. Once more about vitamin deficit. Clinical Oncohematology. 2009;2(1):185-195. (In Russ.). https://cyberleninka.ru/article/n/esche-raz-o-defitsite-vitamina-v12/viewer
  29. Kennedy DO. B Vitamins and the Brain: Mechanisms, Dose and Efficacy — A Review. Nutrients. 2016;8(2):68.  https://doi.org/10.3390/nu8020068
  30. Wong CW. Vitamin deficiency in the elderly: is it worth screening? Hong Kong Med J. 2015;21(2):155-164.  https://doi.org/10.12809/hkmj144383
  31. Pawlak R, Parrott SJ, Raj S, et al. How prevalent is vitamin B(12) deficiency among vegetarians? Nutr Rev. 2013;71(2):110-117.  https://doi.org/10.1111/nure.12001
  32. Kamchatnov PR, Damulin IV. Cognitive impairments in vitamin and folic deficiencies and hyperhomocysteinemia. The Clinician. 2015;9(1):18-23. (In Russ.). https://doi.org/10.17650/1818-8338-2015-1-18-23
  33. Bram D, Bubrovszky M, Durand JP, et al. Pernicious anemia presenting as catatonia: correlating vitamin levels and catatonic symptoms. Gener Hosp Psychiatry. 2015;37(3):273.e5-7.  https://doi.org/10.1016/j.genhosppsych.2015.02.003
  34. Moore E, Mander A, Ames D, et al. Cognitive impairment and vitamin : a review. Int Psychogeriatr. 2012;24(4):541-556.  https://doi.org/10.1017/S1041610211002511
  35. Goldstein DS, Sharabi Y. Neurogenic orthostatic hypotension: a pathophysiological approach. Circulation. 2009;119(1):139-146.  https://doi.org/10.1161/CIRCULATIONAHA.108.805887
  36. Blundo C, Marin D, Ricci M. Vitamin deficiency associated with symptoms of frontotemporal dementia. Neurol Sci. 2011;32:101-105.  https://doi.org/10.1007/s10072-010-0419-x
  37. Clark CM. Metabolic and nutritional disorders associated with dementia. In: Morris J.C., Galvin J.E., Holzman D.M. (eds.). Handbook of Dementing Illnesses. New York, NY: Marcel Dekker, Inc.; 1994;413-439. 
  38. Vogiatzoglou A, Refsum H, Johnston C, et al. Vitamin status and rate of brain volume loss in community-dwelling elderly. Neurology. 2008;71(11):826-832.  https://doi.org/10.1212/01.wnl.0000325581.26991.f2
  39. Reynolds EH. Folic acid, ageing, depression, and dementia. BMJ. 2002;324(7352):1512-1515. https://doi.org/10.1136/bmj.324.7352.1512
  40. Langan RC, Goodbred AJ. Vitamin Deficiency: Recognition and Management. Am Fam Physician. 2017;96(6):384-389.  https://www.aafp.org/afp/2017/0915/p384.html
  41. Jordan JT, Weiser J, van Ness PC. Unrecognized cobalamin deficiency, nitrous oxide, and reversible subacute combined degeneration. Neurol Clin Pract. 2014;4(4):358-361.  https://doi.org/10.1212/CPJ.0000000000000014
  42. Valente E, Scott JM, Ueland PM, et al. Diagnostic accuracy of holotranscobalamin, methylmalonic acid, serum cobalamin, and other indicators of tissue vitamin B₁₂ status in the elderly. Clin Chem. 2011;57(6):856-863.  https://doi.org/10.1373/clinchem.2010.158154
  43. Baroni L, Bonetto C, Rizzo G, et al. Association Between Cognitive Impairment and Vitamin, Folate, and Homocysteine Status in Elderly Adults: A Retrospective Study. J Alzheimers Dis. 2019;70(2):443-453.  https://doi.org/10.3233/JAD-190249
  44. Chatthanawaree W. Biomarkers of cobalamin (vitamin ) deficiency and its application. J Nutr Health Aging. 2011;15:227-231.  https://doi.org/10.1007/s12603-010-0280-x
  45. Hill MH, Flatley JE, Barker ME, et al. A vitamin B-12 supplement of 500 μg/d for eight weeks does not normalize urinary methylmalonic acid or other biomarkers of vitamin B-12 status in elderly people with moderately poor vitamin B-12 status. J Nutr. 2013;143(2):142-147.  https://doi.org/10.3945/jn.112.169193
  46. Briani C, Dalla Torre C, Citton V, et al. Cobalamin Deficiency: Clinical Picture and Radiological Findings. Nutrients. 2013;5(11):4521-4539. https://doi.org/10.3390/nu5114521
  47. Meng H, Li Y, Zhang W, et al. The relationship between cognitive impairment and homocysteine in a and folate deficient population in China: A cross-sectional study. Medicine (Baltimore). 2019;98(47):e17970. https://doi.org/10.1097/MD.0000000000017970
  48. Ellinson M, Thomas J, Patterson A. A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet. 2004;17(4):371-383; quiz 385-387.  https://doi.org/10.1111/j.1365-277X.2004.00532.x
  49. Soh Y, Lee DH, Won CW. Association between Vitamin levels and cognitive function in the elderly Korean population. Medicine (Baltimore). 2020;99(30):e21371. https://doi.org/10.1097/MD.0000000000021371
  50. Vogiatzoglou A, Smith AD, Nurk E, et al. Cognitive function in an elderly population: interaction between vitamin status, depression, and apolipoprotein E ε4: the Hordaland Homocysteine Study. Psychosom Med. 2013;75(1):20-29.  https://doi.org/10.1097/PSY.0b013e3182761b6c
  51. Malouf R, Areosa Sastre A. Vitamin for cognition. Cochrane Database Syst Rev. 2003;(3):CD004326. https://doi.org/10.1002/14651858.CD004326
  52. Health Quality Ontario. Vitamin and cognitive function: an evidence-based analysis. Ont Health Technol Assess Ser. 2013;13(23):1-45.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874776/
  53. Dangour AD, Allen E, Clarke R, et al. Effects of vitamin B-12 supplementation on neurologic and cognitive function in older people: a randomized controlled trial. Am J Clin Nutr. 2015;102(3):639-647.  https://doi.org/10.3945/ajcn.115.110775
  54. Seal EC, Metz J, Flicker L, Melny J. A randomized, double-blind, placebo-controlled study of oral vitamin supplementation in older patients with subnormal or borderline serum vitamin concentrations. J Am Geriatr Soc. 2002;50(1):146-151.  https://doi.org/10.1046/j.1532-5415.2002.50020.x
  55. Eussen SJ, de Groot LC, Joosten LW, et al. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr. 2006;84(2):361-370.  https://doi.org/10.1093/ajcn/84.1.361
  56. Rietsema WJ. Unexpected recovery of moderate cognitive impairment on treatment with oral methylcobalamin. J Am Geriatr Soc. 2014;62(8):1611-1612. https://doi.org/10.1111/jgs.12966
  57. Boucher M, Bryan S, Dukes S. Deficiency or dementia? Exploring deficiency after urostomy. Br J Nurs. 2015;24(11):594-597.  https://doi.org/10.12968/bjon.2015.24.11.594
  58. De Lau LM, Smith AD, Refsum H, et al. Plasma vitamin status and cerebral white — matter lesions. J Neurol Neurosurg Psychiatry. 2009;80(2):149-157.  https://doi.org/10.1136/jnnp.2008.149286
  59. Djukic M, Wedekind D, Franz A, et al. Frequency of dementia syndromes with a potentially treatable cause in geriatric in-patients: analysis of a 1-year interval. Eur Arch Psychiatry Clin Neurosci. 2015;265(5):429-438.  https://doi.org/10.1007/s00406-015-0583-3
  60. Devalia V, Hamilton MS, Molloy AM; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496-513.  https://doi.org/10.1111/bjh.12959
  61. Carmel R. How I treat cobalamin (vitamin) deficiency. Blood. 2008;112(6):2214-2221. https://doi.org/10.1182/blood-2008-03-040253
  62. Wang H, Li L, Qin LL, et al. Oral vitamin versus intramuscular vitamin for vitamin deficiency. Cochrane Database Syst Rev. 2018;3(3):CD004655. https://doi.org/10.1002/14651858.CD004655.pub3
  63. Eussen SJ, de Groot LC, Clarke R, et al. Oral cyanocobalamin supplementation in older people with vitamin deficiency: a dose-finding trial. Arch Intern Med. 2005;165(10):1167-1172. https://doi.org/10.1001/archinte.165.10.1167
  64. Kuzminski AM, Del Giacco EI, Allen RH, et al. Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 1998;92:1191-1198. https://doi.org/10.1182/blood.V92.4.1191
  65. Bolaman Z, Kadikoylu G, Yukselen V, et al. Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label study. Clin Ther. 2003;25(12):3124-3134. https://doi.org/10.1016/s0149-2918(03)90096-8
  66. Sanz-Cuesta T, González-Escobar P, Riesgo-Fuertes R, et al.; O Group. Oral versus intramuscular administration of vitamin for the treatment of patients with vitamin deficiency: a pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (Project O). BMC Public Health. 2012;12:394.  https://doi.org/10.1186/1471-2458-12-394
  67. Bouma M, Burgers J, Drost B, et al. NHG-standaard anemie. Huisarts Wet. 2014;57:528-536.  https://www.henw.org/files/2018-05/H%26W10_LR_1.pdf
  68. Nyholm E, Turpin P, Swain D, et al. Oral vitamin can change our practice. Postgrad Med J. 2003;79(930):218-220.  https://doi.org/10.1136/pmj.79.930.218
  69. Lin J, Kelsberg G, Safranek S. Clinical inquiry: Is high-dose oral a safe and effective alternative to a injection? J Fam Pract. 2012;61:162-163. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.